Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;100(1):13-7.
doi: 10.2105/AJPH.2008.147629.

New opportunities for the management and therapy of hepatitis C in correctional settings

C Kent Martin  1 , Jeffrey E Hostetter, John J Hagan
Affiliations

New opportunities for the management and therapy of hepatitis C in correctional settings

C Kent Martin et al. Am J Public Health. 2010 Jan.

Abstract

Hepatitis C in prison populations is now a major public health problem, and large numbers of correctional facilities have no comprehensive management program, often because of formidable projected costs and tightening budget constraints. The North Dakota Department of Corrections and Rehabilitation has operated a management and therapy program since 2002 using consensus interferon and ribavirin with 45% cost savings. The program has provided excellent sustained viral responses: 54.2% for genotype 1 hepatitis C, 75% for genotypes 2 and 3, and 63.6% overall.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Treatment protocol for hepatitis C therapy using consensus interferon and ribavirin: North Dakota Department of Corrections and Rehabilitation, July 2002–November 2008. Note. BID = twice daily; MCG = micrograms. a15 mcg subcutaneously three times a week.
FIGURE 2
FIGURE 2
Outcomes of hepatitis C therapy using consensus interferon and ribavirin: North Dakota Department of Corrections and Rehabilitation, July 2002–November 2008. Note. SVR = sustained virologic response; EVR = early virologic response. aAll genotype 1. bFour genotype 1, one genotype 3 and one genotype 4. cOne inmate quit voluntarily, one inmate discontinued due to illegal drug use, and one inmate failed EVR.
See this image and copyright information in PMC

References

    1. Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and appropriate response. Am J Public Health 2006;96(6):974–978 - PMC - PubMed
    1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C in the United States, 1988 through 1994. N Engl J Med 1999;341(8):556–562 - PubMed
    1. Guidelines for the prevention and treatment of hepatitis C and cirrhosis Federal Bureau of Prisons—Clinical Practice Guidelines. 2009. Available at: http://www.bop.gov/news/PDFs/hepatitis_c.pdf. Accessed October 22, 2009
    1. Sterling R, Hofmann C, Luketic V, et al. Treatment of chronic hepatitis C virus in the Virginia Department of Corrections: can compliance overcome racial differences to response? Am J Gastroenterol 2004;99(5):866–872 - PubMed
    1. Tan J, Joseph T, Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology 2008;48(5):1387–1395 - PubMed

Publication types

MeSH terms